The Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI), has recommended to the Central Drugs Standard Control Organisation (CDSCO) for regulatory actions against 24 drugs which have been found to show adverse drug reactions (ADRs). These 24 drugs have been reviewed by the Signal Review Panel (constituted by doctors working in both public and private sector) of the Pharmacovigilance Cell of India, which asked the CDSCO to take appropriate regulatory action against the drugs.
They said that, “It is very important to have specific drug safety signals so that healthcare professionals are aware of the consequences of the drugs.” S.No Drug Adverse reaction PvPI recommendation 1 Carbamazepine Stevens-Johnson Syndrome where both layers of the skin are burnt and Toxic Epidermal Necrolysis Patient may be screened…
